Absolutely.
There is not going to be squat for investment monies rolling in here without a few huge news items. Mainly financing to mitigate CD conversions and new CEO and Andrews/IND/FDA update.
The volume recently is peanuts in terms of dollars and the large blocks are most likely either MM shuffling shares/positioning or a renewed dilution from cd conversion which conversions have been idle since October, so that would be odd. Bid/Ask is meaningless at this point.
I don't know how a large sum of money comes into this baggage without forming a new entity. They can secure the patent with the preferred convertibles per Dawson arrangement filing.
"Supposedly".. there is new IR coming, middle east potential, Andrews wrapping up evaluation, etc, blah, blah.. all that is message board talk until put into print and announced by the company. The CEO is clearly prioritizing his other businesses.
However, there are multiple viable paths to unlock the potential of these patents and their market opportunity. The mrkt valuation is merely 1 million, so that too is peanuts in comparison.
Hard to overcome incompetant greed however.. New leadership, new money and new advisors required! Dawson James guidance is very crticial, IMO.
AI
